Pati P, Buyse M, Larsimont D, Bontempi G, Delorenzi M, Piccart
Pati P, Buyse M, Larsimont D, Bontempi G, Delorenzi M, Piccart M, Sotiriou C: Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 2008, 14:5158-5165. Iwamoto T, Bianchini G, Booser D, Qi Y, Coutant C, Ya-Hui Shiang C, Santarpia L, Matsuoka J, Hortobagyi GN, Symmans WF, Holmes FA, O’Shaughnessy J, Hellerstedt B, Pippen J, Andre F, Simon R, Pusztai L: Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer. J Natl Cancer Inst 2011, 103:264-272. Foulkes WD, Smith IE, Reis-Filho JS: Triple-negative breast cancer. N Engl J Med 2010, 363:1938-1948. Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T, Davies SR, Snider J, Stijleman IJ, Reed J, Cheang MC, Mardis ER, Perou CM, Bernard PS, Ellis MJ: A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptorpositive breast cancer. Clin Cancer Res 2010, 16:5222-5232. Pusztai L, Mazouni C, Anderson K, Wu Y, Symmans WF: Molecular classification of breast cancer: limitations and potential. Oncologist 2006, 11:868-877. Kapp AV, Tibshirani R: Are clusters found in one dataset present in another dataset? Biostatistics 2007, 8:9-31. Loi S, Sotiriou C, Buyse M, Rutgers E, Van’t Veer L, Piccart M, Cardoso F: Molecular forecasting of breast cancer: time to move forward with clinical testing. J Clin Oncol 2006, 24:721-722; author reply 722-723. Mackay A, Weigelt B, Grigoriadis A, Kreike B, Natrajan R, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/29045898 RO5186582MedChemExpress RG1662 A’Hern R, Tan DS, Dowsett M, Ashworth A, Reis-Filho JS: Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement. J Natl Cancer Inst 2011, 103:662-673. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM: The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006, 7:96. Weigelt B, Mackay A, A’Hern R, Natrajan R, Tan DS, Dowsett M, Ashworth A, Reis-Filho JS: Breast cancer molecular profiling with single sample predictors: a retrospective analysis. Lancet Oncol 2010, 11:339-349. Haibe-Kains B, Culhane A, Desmedt C, Bontempi G, Quackenbush J, Sotiriou C: Robusteness of breast cancer molecular subtypes identification. Abstract Book of the IMPAKT 2010 Breast Cancer Conference, Brussels, Belgium, 6-8 May 2010. Ann Oncol 2010, 21:iv49-iv59. Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA: Challenges in projecting clustering results across gene expression-profiling datasets. J Natl Cancer Inst 2007, 99:1715-1723. Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, S lie T, Dai H, He YD, van’t Veer LJ, Bartelink H, van de Rijn M, Brown PO, van de Vijver MJ: Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 2005, 102:3738-3743. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van’t Veer LJ, Perou CM: Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 2006, 355:560-569. Weigelt B, Geyer FC, Reis-Filho JS: Histological types of breast cancer: how special are they? Mol Oncol 2010, 4.